Science & Research

Researchers at the University of Washington are undertaking a study to measure the effects of cannabis use during pregnancy.

Researchers at the University of Washington are investigating the efficacy of CBD for Fragile X syndrome, a type of autism that may be linked to cannabinoid deficiencies.

New York-based cannabis investor Bob Broderick has announced a $9 million donation to MIT and Harvard for researching the cannabis plant.

A strong majority of cannabis consumers say they prefer cannabis use to alcohol consumption; 45 percent said they would likely replace some of their drinking with cannabis in the future.

According to a recent University of Colorado Boulder study, 81.7 percent of respondents enjoy combining the use of cannabis with their exercise regimens.

Medical cannabis patients in Minnesota have reported a “significant reduction” in the severity of their cancer symptoms.

The investment will span five years and will cover applications for basic science, clinical, health services, and policy cannabis research.

Some 40 percent of U.S. adults who are 21 or older say they are interested in experimenting with CBD products.

A stoned driving study launching in Colorado hopes to help determine an accurate roadside cannabis intoxication test.

Experts are using DNA to better understand the many differences in how we experience cannabis as individuals.

Raphael Mechoulam, the first person to isolate and synthesize THC, has joined the scientific advisory committee of Israel-based medical cannabis producer Cannbit.

Researchers at the University of New Mexico have uncovered a stronger-than-expected correlation of symptom relief with THC.

Researchers at the University of California, Berkeley have extracted cannabinoids from brewers yeast.

A study of the Denver area found that the presence of a medical cannabis dispensary indicated temporarily higher crime rates. This could, however, be the result of increased police targeting or simply a temporary effect of a new, cash-only business.

A re-analysis of an oft-cited 2015 study showing cannabis reforms to be associated with increased adolescent use has found the initial conclusion was flawed.

An analysis of state-legal medical cannabis programs shows that 85% of the reasons reported for seeking medical cannabis show conclusive scientific evidence that cannabis is an effective treatment.

In the study, more than 80 percent of children with autism saw moderate to substantial improvement of their symptoms.

The study shows that not only do they have higher-than-average sperm counts but they are also less likely to have below-average sperm counts.

While cannabis consumption is up across the nation and cannabis dependency is down, liberal states are showing a greater gap between the two — lower dependency despite even higher consumption.

The study hopes to correct a lack of double-blind, placebo-controlled studies regarding cannabis’ effects on cancer symptoms.

Positive drug test results are up across the country, with the largest increases in states with recent legalization and in safety-sensitive jobs.

CBD content in European cannabis products, however, has not risen alongside its psychoactive counterpart.

The analysis reveals no connection between additional miles of border fence and the rate of cannabis seizures but does reveal a large drop in seizures following the launch of state-legal sales.

The study, conducted in the Netherlands, found evidence that THC extract from cannabis is useful as a treatment for fibromyalgia pain. Notably, researchers suggest it is far more effective than purely CBD extract.